ZYBERNO
Stock Report
Updated Aug 26, 2026

HEARTBEAM, INC. (BEATW)

Healthcare • NASDAQ

$0.02

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
18.0/100
POOR BUSINESS
HEARTBEAM, INC. (BEATW) scores 18/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-686.8%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.23x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-1,167.4%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

HEARTBEAM, INC. (BEATW) stock report — Zyberno Score 18/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, BEATW generated -$13.18M in Owner Earnings. Capital was deployed as follows: $846.00K invested in capital expenditures. Reinvestment rate: -3.7%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.02
Market Cap:$897.17K

Valuation Multiples (2)

P/B Ratio:0.11x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$5.97M

Price Action & Momentum (1)

% of 52-Week High:3.0%
B. Profitability Assessment

Return Metrics (5)

ROA:-348.7%
Reinvestment Rate:-3.7%
Fundamental Growth Rate (g):42.7%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$3.00K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-17.6%
Latest Earnings Filed:2026-08-13
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.66x
Quick Ratio:3.61x
Cash Ratio:3.55x

Leverage Analysis (3)

Debt To Equity Ttm:0.23x
Debt-to-Equity Ratio:0.23x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:6,536,000.00
Cash And Cash Equivalents:8,722,000.00
Long Term Debt:$0.00
Net Debt:-$6.87M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$20.41M

Bottom Line Performance (3)

-$20.30M
Income Before Tax:-$20.30M
Ebitda Ttm:-20,349,000.00

Operating Expenses (5)

Operating Expenses:20,406,000.00
R And D Expense:11,330,000.00
Sga Expense:9,076,000.00
Income Tax Expense:$0.00
Interest Expense:0.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$10.64M
Current Assets:$9.00M
Ppe Net:1,584,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:2,460,000.00
Current Liabilities:2,460,000.00
Long Term Debt:$0.00
Short Term Debt:$1.86M

Equity & Capital (3)

Equity:$8.18M
Retained Earnings:-$87.03M
Common Stock:100,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:110,000.00
Accounts Payable:1,852,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:1,701,000,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$13.12M-$13.97M

Investment Activities (2)

Investing Cash Flow:-$246.00K
Capital Expenditures Ttm:846,000.00

Financing Activities (3)

Financing Cash Flow:$1.52M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:1,500,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:57,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.51
-$0.51
Earnings Per Share Ttm:-$0.38

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$0.27

Book Value & Capital (2)

Book Value Per Share:$0.15
Cash Per Share:0.17

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:30.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$13.18M

Damodaran Growth Analysis (2)

Reinvestment Rate:-3.7%
Fundamental Growth Rate (g):42.7%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):-39.5%
C. Company Profile & Context

Corporate Information (6)

Symbol:BEATW
Company Name:HEARTBEAM, INC.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:52.77M
Shares Outstanding Basic:52.77M
Shares Outstanding Diluted:52.77M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-26 08:09:27 UTC
Data Timestamp:2026-08-26T08:09:27.731713
Scroll to Top